StockData
10x Genomics, Inc. logo

10x Genomics, Inc. (TXG) stock

TXGNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 9/30113% above fair value
$57.07+0.77 (+1.37%)

Close on Nov 18, 2026Market cap $7.44BP/E –Yield –

10x Genomics free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

10x Genomics's free cash flow for the twelve months ending Sep 30, 2026 was $93.77M, up 14.8% year over year. For fiscal 2025 it was $130.12M. The highest annual figure on record is $130.12M in fiscal 2025.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$130.12M–
FY2024Dec 31, 2024-$5.73M–
FY2023Dec 31, 2023-$63.80M–
FY2022Dec 31, 2022-$165.27M–
FY2021Dec 31, 2021-$122.65M–
FY2020Dec 31, 2020-$254.56M–
FY2019Dec 31, 2019-$8.12M–
FY2018Dec 31, 2018-$82.69M–
FY2017Dec 31, 2017-$14.46M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$14.86M-65.1%
Q2 FY2026Jun 30, 2026$15.39M-4.6%
Q1 FY2026Mar 31, 2026$24.52M-24.4%
Q4 FY2025Dec 31, 2025$39.00M–
Q3 FY2025Sep 30, 2025$42.53M+139.6%
Q2 FY2025Jun 30, 2025$16.13M+249.3%
Q1 FY2025Mar 31, 2025$32.46M–
Q4 FY2024Dec 31, 2024-$9.46M-142.4%
Q3 FY2024Sep 30, 2024$17.75M–
Q2 FY2024Jun 30, 2024$4.62M–
Q1 FY2024Mar 31, 2024-$18.64M–
Q4 FY2023Dec 31, 2023$22.31M–
Q3 FY2023Sep 30, 2023-$40.54M–
Q2 FY2023Jun 30, 2023-$36.88M–
Q1 FY2023Mar 31, 2023-$8.68M–
Q4 FY2022Dec 31, 2022-$26.01M–
Q3 FY2022Sep 30, 2022-$46.14M–
Q2 FY2022Jun 30, 2022-$44.18M–
Q1 FY2022Mar 31, 2022-$48.94M–
Q4 FY2021Dec 31, 2021-$21.81M–
Q3 FY2021Sep 30, 2021-$46.44M–
Q2 FY2021Jun 30, 2021-$11.45M–
Q1 FY2021Mar 31, 2021-$42.95M–
Q4 FY2020Dec 31, 2020-$151.51M-105318.1%
Q3 FY2020Sep 30, 2020-$56.14M-6720.0%
Q2 FY2020Jun 30, 2020-$36.26M–
Q1 FY2020Mar 31, 2020-$10.66M–
Q4 FY2019Dec 31, 2019$144.00K–
Q3 FY2019Sep 30, 2019$848.00K–
Q2 FY2019Jun 30, 2019-$9.06M–
Q1 FY2019Mar 31, 2019-$49.00K–
Q4 FY2018Dec 31, 2018-$53.40M–

More 10x Genomics figures

See a number that looks wrong?